LivaNova PLC
LIVN
Cena:
Valuace
78
Růst
56
Zdraví
55
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 7.3 mil | 13.43% | 0.00% | 0.01% | 2024-09-30 |
| BLACKROCK, INC. | 7.1 mil | 13.10% | 0.00% | 0.01% | 2024-09-30 |
| BLACKROCK INC. | 6.9 mil | 12.73% | 0.00% | 0.01% | 2015-12-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 4.2 mil | 7.72% | 0.01% | 0.21% | 2018-12-31 |
| FMR LLC | 2.7 mil | 4.89% | 0.01% | 0.01% | 2020-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 2.5 mil | 4.58% | 0.00% | 0.07% | 2017-06-30 |
| MILLENNIUM MANAGEMENT LLC | 2.4 mil | 4.47% | -0.03% | 0.06% | 2015-12-31 |
| VANGUARD GROUP INC | 2.3 mil | 4.27% | 0.00% | 0.00% | 2015-12-31 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.1 mil | 3.90% | 0.00% | 0.22% | 2024-12-31 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 2.1 mil | 3.82% | 0.00% | 0.02% | 2024-06-30 |
| STATE STREET CORP | 2.1 mil | 3.80% | 0.00% | 0.00% | 2015-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.9 mil | 3.47% | 0.00% | 0.02% | 2024-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 1.8 mil | 3.35% | 0.00% | 0.02% | 2015-12-31 |
| AMERICAN CENTURY COMPANIES INC | 1.8 mil | 3.29% | 0.02% | 0.06% | 2023-06-30 |
| INVESCO LTD. | 1.6 mil | 2.98% | 0.01% | 0.02% | 2015-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5 mil | 2.75% | 0.00% | 0.01% | 2015-12-31 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 1.3 mil | 2.39% | -0.20% | 0.24% | 2020-06-30 |
| CONGRESS ASSET MANAGEMENT CO /MA | 1.3 mil | 2.34% | 0.58% | 0.58% | 2026-03-31 |
| GREENLIGHT CAPITAL INC | 1.2 mil | 2.28% | -0.46% | 3.11% | 2021-06-30 |
| REDMILE GROUP, LLC | 926.80 tis | 1.70% | 0.25% | 4.72% | 2021-03-31 |
| NUVEEN, LLC | 920.34 tis | 1.69% | 0.00% | 0.02% | 2025-03-31 |
| LOOMIS SAYLES & CO L P | 852.44 tis | 1.57% | -0.01% | 0.06% | 2022-03-31 |
| VICTORY CAPITAL MANAGEMENT INC | 833.27 tis | 1.53% | 0.00% | 0.03% | 2019-09-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 823.41 tis | 1.52% | 0.00% | 0.01% | 2018-06-30 |
| GOLDMAN SACHS GROUP INC | 798.95 tis | 1.47% | 0.00% | 0.01% | 2015-12-31 |
| GREENHOUSE FUNDS LLLP | 768.30 tis | 1.41% | 1.92% | 2.19% | 2025-12-31 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 710.39 tis | 1.31% | 2.97% | 3.41% | 2024-03-31 |
| LSV ASSET MANAGEMENT | 695.41 tis | 1.28% | 0.00% | 0.10% | 2024-12-31 |
| EMERALD ADVISERS, LLC | 670.21 tis | 1.23% | 0.02% | 1.35% | 2023-03-31 |
| NORTHERN TRUST CORP | 666.31 tis | 1.22% | 0.00% | 0.01% | 2015-12-31 |
| CITADEL ADVISORS LLC | 651.76 tis | 1.20% | -0.01% | 0.01% | 2015-12-31 |
| 648.23 tis | 1.19% | 0.00% | 0.00% | 2026-03-31 | |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 636.54 tis | 1.17% | 0.41% | 0.41% | 2026-03-31 |
| NORGES BANK | 623.73 tis | 1.15% | 0.01% | 0.01% | 2024-06-30 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 620.11 tis | 1.14% | -0.01% | 0.11% | 2024-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 610.14 tis | 1.12% | 0.00% | 0.01% | 2015-12-31 |
| DME CAPITAL MANAGEMENT, LP | 603.55 tis | 1.11% | -0.41% | 1.32% | 2024-03-31 |
| MORGAN STANLEY | 594.07 tis | 1.09% | 0.00% | 0.00% | 2015-12-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 582.50 tis | 1.07% | 0.21% | 1.50% | 2025-12-31 |
| ODDO BHF ASSET MANAGEMENT SAS | 569.23 tis | 1.04% | 0.56% | 1.13% | 2025-06-30 |
| MAGNETAR FINANCIAL LLC | 564.20 tis | 1.04% | -0.23% | 0.60% | 2022-06-30 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 556.55 tis | 1.02% | -0.08% | 0.11% | 2024-12-31 |
| MAN GROUP PLC | 547.78 tis | 1.01% | 0.00% | 0.07% | 2022-03-31 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 543.72 tis | 1.00% | 0.03% | 0.25% | 2025-09-30 |
| SCOPIA CAPITAL MANAGEMENT LP | 538.39 tis | 0.99% | 1.57% | 6.84% | 2025-06-30 |
| BANK OF AMERICA CORP /DE/ | 533.02 tis | 0.98% | 0.00% | 0.00% | 2015-12-31 |
| ALLIANCEBERNSTEIN L.P. | 525.80 tis | 0.97% | -0.02% | 0.01% | 2015-12-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 512.43 tis | 0.94% | 0.00% | 0.02% | 2015-12-31 |
| CLEARLINE CAPITAL LP | 499.34 tis | 0.92% | -0.40% | 1.36% | 2022-06-30 |
| FREESTONE GROVE PARTNERS LP | 498.85 tis | 0.92% | 0.28% | 0.28% | 2024-12-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 495.62 tis | 0.91% | 0.19% | 0.25% | 2023-03-31 |
| P2 CAPITAL PARTNERS, LLC | 493.90 tis | 0.90% | 2.81% | 7.79% | 2021-12-31 |
| JANUS HENDERSON GROUP PLC | 471.38 tis | 0.86% | 0.01% | 0.01% | 2021-09-30 |
| JPMORGAN CHASE & CO | 464.14 tis | 0.85% | 0.00% | 0.00% | 2015-12-31 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 454.33 tis | 0.83% | 0.03% | 1.40% | 2023-03-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 451.25 tis | 0.83% | 0.00% | 0.03% | 2020-06-30 |
| PERCEPTIVE ADVISORS LLC | 429.00 tis | 0.79% | -0.10% | 0.48% | 2024-03-31 |
| SIO CAPITAL MANAGEMENT, LLC | 421.62 tis | 0.77% | 0.72% | 3.84% | 2025-12-31 |
| PARADICE INVESTMENT MANAGEMENT LLC | 417.51 tis | 0.77% | -1.17% | 4.98% | 2017-03-31 |
| HAWK RIDGE CAPITAL MANAGEMENT LP | 410.16 tis | 0.76% | -0.90% | 1.03% | 2020-12-31 |
| AMERIPRISE FINANCIAL INC | 408.59 tis | 0.75% | 0.00% | 0.01% | 2015-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 403.97 tis | 0.74% | 0.24% | 2.65% | 2024-03-31 |
| BANK OF NEW YORK MELLON CORP | 394.39 tis | 0.72% | 0.00% | 0.00% | 2015-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 381.08 tis | 0.70% | 0.03% | 0.03% | 2025-12-31 |
| UBS GROUP AG | 370.07 tis | 0.68% | 0.00% | 0.00% | 2015-12-31 |
| KENNEDY CAPITAL MANAGEMENT LLC | 364.41 tis | 0.67% | 0.17% | 0.49% | 2017-09-30 |
| D. E. SHAW & CO., INC. | 362.61 tis | 0.66% | -0.02% | 0.01% | 2015-12-31 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 360.60 tis | 0.66% | 0.02% | 0.03% | 2025-03-31 |
| CAPTION MANAGEMENT, LLC | 336.40 tis | 0.62% | 0.15% | 0.28% | 2024-03-31 |
| OBERWEIS ASSET MANAGEMENT INC/ | 321.90 tis | 0.59% | 0.13% | 0.60% | 2023-12-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 321.44 tis | 0.59% | 0.00% | 0.05% | 2020-09-30 |
| ROYAL BANK OF CANADA | 316.31 tis | 0.58% | 0.00% | 0.00% | 2015-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 309.39 tis | 0.57% | 0.01% | 0.01% | 2026-03-31 |
| ALGERT GLOBAL LLC | 306.20 tis | 0.56% | 0.12% | 0.29% | 2023-03-31 |
| PANAGORA ASSET MANAGEMENT INC | 293.44 tis | 0.54% | 0.01% | 0.07% | 2022-03-31 |
| BOONE CAPITAL MANAGEMENT LLC | 288.90 tis | 0.53% | 2.69% | 5.58% | 2025-09-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 288.34 tis | 0.53% | 0.01% | 0.01% | 2026-03-31 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 280.73 tis | 0.52% | -0.25% | 1.13% | 2024-03-31 |
| DARK FOREST CAPITAL MANAGEMENT LP | 275.05 tis | 0.51% | 0.31% | 0.49% | 2024-12-31 |
| TREXQUANT INVESTMENT LP | 273.46 tis | 0.50% | 0.00% | 0.15% | 2023-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 269.56 tis | 0.49% | 0.00% | 0.01% | 2023-12-31 |
| CITIGROUP INC | 260.60 tis | 0.48% | 0.00% | 0.01% | 2015-12-31 |
| M&G PLC | 261.38 tis | 0.48% | 0.06% | 0.06% | 2025-06-30 |
| TWO SIGMA INVESTMENTS, LP | 259.57 tis | 0.48% | -0.01% | 0.02% | 2022-09-30 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 258.86 tis | 0.47% | 0.00% | 0.04% | 2022-03-31 |
| WELLS FARGO & COMPANY/MN | 256.50 tis | 0.47% | 0.00% | 0.00% | 2015-12-31 |
| RAYMOND JAMES FINANCIAL INC | 255.42 tis | 0.47% | 0.00% | 0.00% | 2024-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 249.20 tis | 0.46% | 0.01% | 0.06% | 2015-12-31 |
| BARCLAYS PLC | 249.29 tis | 0.46% | 0.00% | 0.00% | 2015-12-31 |
| ABRDN PLC | 246.29 tis | 0.45% | 0.00% | 0.02% | 2023-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 243.87 tis | 0.45% | 0.00% | 0.00% | 2017-09-30 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 237.91 tis | 0.44% | 0.04% | 0.05% | 2022-09-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 238.17 tis | 0.44% | 0.00% | 0.02% | 2017-06-30 |
| GREAT LAKES ADVISORS, LLC | 237.02 tis | 0.43% | -0.01% | 0.09% | 2023-03-31 |
| TWO SIGMA ADVISERS, LP | 229.85 tis | 0.42% | 0.00% | 0.02% | 2021-03-31 |
| PERPETUAL LTD | 222.72 tis | 0.41% | 0.01% | 0.13% | 2023-03-31 |
| SG CAPITAL MANAGEMENT LLC | 221.98 tis | 0.41% | 2.06% | 2.06% | 2024-06-30 |
| SEI INVESTMENTS CO | 218.81 tis | 0.40% | 0.00% | 0.01% | 2017-09-30 |
| MARSHALL WACE, LLP | 216.58 tis | 0.40% | -0.01% | 0.01% | 2021-09-30 |
| PRINCIPAL FINANCIAL GROUP INC | 212.74 tis | 0.39% | 0.00% | 0.01% | 2015-12-31 |
| WALLEYE CAPITAL LLC | 213.60 tis | 0.39% | -0.07% | 0.06% | 2024-12-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 206.54 tis | 0.38% | 0.07% | 0.22% | 2022-06-30 |
| CINCTIVE CAPITAL MANAGEMENT LP | 206.22 tis | 0.38% | 0.19% | 0.59% | 2024-06-30 |
| POINT72 (DIFC) LTD | 202.42 tis | 0.37% | 0.02% | 0.34% | 2024-03-31 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 201.83 tis | 0.37% | 0.00% | 0.02% | 2021-12-31 |
| JANE STREET GROUP, LLC | 199.49 tis | 0.37% | 0.00% | 0.00% | 2017-09-30 |
| AMUNDI | 196.44 tis | 0.36% | 0.00% | 0.00% | 2022-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 192.64 tis | 0.35% | 0.01% | 0.05% | 2024-03-31 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 190.00 tis | 0.35% | 0.79% | 1.09% | 2025-06-30 |
| RHUMBLINE ADVISERS | 183.13 tis | 0.34% | 0.00% | 0.01% | 2015-12-31 |
| POLAR CAPITAL HOLDINGS PLC | 180.20 tis | 0.33% | 0.00% | 0.05% | 2021-06-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 180.38 tis | 0.33% | 0.00% | 0.01% | 2017-03-31 |
| EAGLE ASSET MANAGEMENT INC | 174.42 tis | 0.32% | 0.01% | 0.05% | 2016-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 152.39 tis | 0.28% | 0.00% | 0.01% | 2023-12-31 |
| NISA INVESTMENT ADVISORS, LLC | 144.56 tis | 0.27% | 0.05% | 0.05% | 2018-03-31 |
| FEDERATED HERMES, INC. | 139.33 tis | 0.26% | 0.00% | 0.02% | 2015-12-31 |
| LEGAL & GENERAL GROUP PLC | 114.39 tis | 0.21% | 0.00% | 0.00% | 2016-12-31 |
| TUDOR INVESTMENT CORP ET AL | 109.18 tis | 0.20% | 0.01% | 0.03% | 2021-03-31 |
| SWISS NATIONAL BANK | 106.12 tis | 0.20% | 0.00% | 0.00% | 2015-12-31 |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 105.73 tis | 0.19% | 0.02% | 1.59% | 2022-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Bianchi Francesco | director | S-Sale | 1800 | 75.75 | 27.5 2026 | 7228 |
| Kozmina Natalia | officer: Chief Human Resources Officer | A-Award | 3264 | 0.00 | 1.4 2026 | 3264 |
| Kozmina Natalia | officer: Chief Human Resources Officer | M-Exempt | 2130 | 0.00 | 1.4 2026 | 4258 |
| Kozmina Natalia | officer: Chief Human Resources Officer | F-InKind | 1374 | 61.27 | 1.4 2026 | 5015 |
| Kozmina Natalia | officer: Chief Human Resources Officer | M-Exempt | 6389 | 0.00 | 1.4 2026 | 6389 |
| Kozmina Natalia | officer: Chief Human Resources Officer | M-Exempt | 4259 | 0.00 | 1.4 2026 | 8518 |
| Kozmina Natalia | officer: Chief Human Resources Officer | A-Award | 9792 | 0.00 | 1.4 2026 | 9792 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 6057 | 0.00 | 1.4 2026 | 0 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 457 | 0.00 | 1.4 2026 | 0 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 1330 | 0.00 | 1.4 2026 | 1329 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 1229 | 0.00 | 1.4 2026 | 2457 |
| Bolton Stephanie | officer: President, Global Epilepsy | A-Award | 2992 | 0.00 | 1.4 2026 | 2992 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 2343 | 0.00 | 1.4 2026 | 4684 |
| Bolton Stephanie | officer: President, Global Epilepsy | A-Award | 8976 | 0.00 | 1.4 2026 | 8976 |
| Bolton Stephanie | officer: President, Global Epilepsy | F-InKind | 8377 | 61.27 | 1.4 2026 | 22189 |
| Bolton Stephanie | officer: President, Global Epilepsy | M-Exempt | 17815 | 0.00 | 1.4 2026 | 30566 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | M-Exempt | 3352 | 0.00 | 1.4 2026 | 6703 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | M-Exempt | 5977 | 0.00 | 1.4 2026 | 11954 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | F-InKind | 11159 | 61.27 | 1.4 2026 | 14167 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | A-Award | 17409 | 0.00 | 1.4 2026 | 17409 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | M-Exempt | 11713 | 0.00 | 1.4 2026 | 23426 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | M-Exempt | 21042 | 0.00 | 1.4 2026 | 25326 |
| Makatsaria Vladimir | director, officer: Chief Executive Officer | A-Award | 52227 | 0.00 | 1.4 2026 | 52227 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 914 | 0.00 | 1.4 2026 | 0 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 10769 | 0.00 | 1.4 2026 | 0 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 2364 | 0.00 | 1.4 2026 | 2364 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 1787 | 0.00 | 1.4 2026 | 3575 |
| Shvartsburg Alex | officer: Chief Financial Officer | A-Award | 5440 | 0.00 | 1.4 2026 | 5440 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 3621 | 0.00 | 1.4 2026 | 7240 |
| Shvartsburg Alex | officer: Chief Financial Officer | A-Award | 16321 | 0.00 | 1.4 2026 | 16321 |
| Shvartsburg Alex | officer: Chief Financial Officer | F-InKind | 12868 | 61.27 | 1.4 2026 | 44647 |
| Shvartsburg Alex | officer: Chief Financial Officer | M-Exempt | 30835 | 0.00 | 1.4 2026 | 57515 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 171 | 0.00 | 1.4 2026 | 0 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 325 | 0.00 | 1.4 2026 | 325 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 558 | 0.00 | 1.4 2026 | 1117 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 2130 | 0.00 | 1.4 2026 | 4258 |
| Poletti Franco | officer: President, Cardiopulmonary | F-InKind | 1370 | 61.27 | 1.4 2026 | 10755 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 3184 | 0.00 | 1.4 2026 | 12125 |
| Tezel Ahmet | officer: Chief Innovation Officer | F-InKind | 1186 | 61.27 | 1.4 2026 | 4157 |
| Tezel Ahmet | officer: Chief Innovation Officer | A-Award | 4624 | 0.00 | 1.4 2026 | 4624 |
| Tezel Ahmet | officer: Chief Innovation Officer | M-Exempt | 3408 | 0.00 | 1.4 2026 | 5343 |
| Tezel Ahmet | officer: Chief Innovation Officer | M-Exempt | 3408 | 0.00 | 1.4 2026 | 6814 |
| Tezel Ahmet | officer: Chief Innovation Officer | A-Award | 13873 | 0.00 | 1.4 2026 | 13873 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 2140 | 57.60 | 13.3 2026 | 0 |
| Poletti Franco | officer: President, Cardiopulmonary | F-InKind | 69 | 62.26 | 13.3 2026 | 8941 |
| Poletti Franco | officer: President, Cardiopulmonary | F-InKind | 1980 | 62.26 | 13.3 2026 | 9010 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 2140 | 57.60 | 13.3 2026 | 10990 |
| Hutchinson Michael Damon | officer: SVP, CLO and Company Secretary | M-Exempt | 2254 | 0.00 | 17.12 2025 | 2253 |
| Hutchinson Michael Damon | officer: SVP, CLO and Company Secretary | F-InKind | 1122 | 63.06 | 17.12 2025 | 6798 |
| Hutchinson Michael Damon | officer: SVP, CLO and Company Secretary | M-Exempt | 2254 | 0.00 | 17.12 2025 | 7920 |
| PODLOGAR SUSAN M | director | M-Exempt | 2355 | 0.00 | 17.12 2025 | 0 |
| PODLOGAR SUSAN M | director | F-InKind | 269 | 63.06 | 17.12 2025 | 2086 |
| PODLOGAR SUSAN M | director | M-Exempt | 2355 | 0.00 | 17.12 2025 | 2355 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 967 | 0.00 | 17.12 2025 | 0 |
| Poletti Franco | officer: President, Cardiopulmonary | F-InKind | 416 | 63.06 | 17.12 2025 | 8850 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 967 | 0.00 | 17.12 2025 | 9266 |
| Story Brooke | director | S-Sale | 250 | 53.94 | 19.11 2025 | 6232 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 643 | 0.00 | 17.9 2025 | 1932 |
| Poletti Franco | officer: President, Cardiopulmonary | F-InKind | 277 | 55.43 | 17.9 2025 | 8299 |
| Poletti Franco | officer: President, Cardiopulmonary | M-Exempt | 643 | 0.00 | 17.9 2025 | 8576 |
| Zurbay Donald | director | A-Award | 2560 | 0.00 | 17.9 2025 | 2560 |
| Zurbay Donald | director | 0 | 0.00 | 4.9 2025 | 0 | |
| Bianchi Francesco | director | S-Sale | 1500 | 56.50 | 27.8 2025 | 9028 |
| PODLOGAR SUSAN M | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| Tezel Ahmet | officer: Chief Innovation Officer | F-InKind | 1032 | 45.76 | 17.6 2025 | 1935 |
| Tezel Ahmet | officer: Chief Innovation Officer | M-Exempt | 2967 | 0.00 | 17.6 2025 | 2967 |
| Tezel Ahmet | officer: Chief Innovation Officer | M-Exempt | 2967 | 0.00 | 17.6 2025 | 8896 |
| WILVER PETER M | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| WILVER PETER M | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| WILVER PETER M | director | F-InKind | 410 | 45.76 | 17.6 2025 | 6738 |
| WILVER PETER M | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 7148 |
| Enxing Seng Stacy | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| Enxing Seng Stacy | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| Enxing Seng Stacy | director | F-InKind | 410 | 45.76 | 17.6 2025 | 11751 |
| Enxing Seng Stacy | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 12161 |
| Story Brooke | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| Story Brooke | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| Story Brooke | director | F-InKind | 410 | 45.76 | 17.6 2025 | 6482 |
| Story Brooke | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 6892 |
| Barry James Christopher | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| Barry James Christopher | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| Barry James Christopher | director | F-InKind | 410 | 45.76 | 17.6 2025 | 4362 |
| Barry James Christopher | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 4772 |
| KOZY WILLIAM A | director | M-Exempt | 4840 | 0.00 | 17.6 2025 | 0 |
| KOZY WILLIAM A | director | A-Award | 5681 | 0.00 | 17.6 2025 | 5681 |
| KOZY WILLIAM A | director | F-InKind | 581 | 45.76 | 17.6 2025 | 32567 |
| KOZY WILLIAM A | director | M-Exempt | 4840 | 0.00 | 17.6 2025 | 33148 |
| SCHERMERHORN TODD C | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| SCHERMERHORN TODD C | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| SCHERMERHORN TODD C | director | F-InKind | 410 | 45.76 | 17.6 2025 | 9063 |
| SCHERMERHORN TODD C | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 9473 |
| Bianchi Francesco | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| Bianchi Francesco | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| Bianchi Francesco | director | F-InKind | 410 | 45.76 | 17.6 2025 | 10528 |
| Bianchi Francesco | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 10938 |
| O'Kane Sharon | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 0 |
| O'Kane Sharon | director | A-Award | 4042 | 0.00 | 17.6 2025 | 4042 |
| O'Kane Sharon | director | F-InKind | 1606 | 45.76 | 17.6 2025 | 11304 |
| O'Kane Sharon | director | M-Exempt | 3416 | 0.00 | 17.6 2025 | 12910 |
| Tezel Ahmet | officer: Chief Innovation Officer | A-Award | 22378 | 39.13 | 1.4 2025 | 22378 |
